Crescent Biopharma (CBIO) Asset Utilization Ratio (2014 - 2026)
Crescent Biopharma's Asset Utilization Ratio came in at 0.01 for Q2 2026, up 141.0% from 0.00 a year earlier and up 15.1% from the prior quarter.
Powered by 
Analysis
Crescent Biopharma (CBIO) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
For FY2025, Crescent Biopharma's Asset Utilization Ratio was 0.08, up 240.1% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.02 in FY2024, 0.00 in FY2023 (-79.9%), 0.00 in FY2022 (-89.5%) and 0.01 in FY2021 (-85.0%).
- The Q2 2026 figure represents the highest quarterly Asset Utilization Ratio since Q1 2025.
- Year-over-year, Asset Utilization Ratio increased in two of the last six quarters, with an average decline of 3.6%.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q1 2023 (growth of 758.4%), and the weakest in Q2 2025 (a decline of 96.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 0.45 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 0.47 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.31 |
| 10 | Crescent Biopharma | 418.60 Mn | -288.70 Mn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.02 |
| Mar 31, 2021 | 0.02 |
API Access
Crescent Biopharma Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "CBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();